CanniMed Therapeutics

CanniMed Therapeutics was a leading Canadian biopharmaceutical company focused on the production and distribution of medical cannabis. Originally established as Prairie Plant Systems in 1988, it was the first producer licensed under Health Canada's medical marijuana regulations to provide products to patients. The company specialized in standardized, pharmaceutical-grade cannabis products, including oils and capsules, designed for clinical applications and rigorous patient care. CanniMed was a pioneer in the industry, emphasizing clinical research and evidence-based applications for cannabinoid therapy. In 2018, the company was acquired by Aurora Cannabis in a landmark deal that consolidated two of Canada's largest cannabis producers. Its legacy continues through integrated operations within the Aurora Cannabis portfolio.